FDA Inspection 1202011 — FDC Limited
The FDA completed an inspection of FDC Limited on February 12, 2023 in Aurangabad, Maharashtra State. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aurangabad, Maharashtra State (India)